Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Sarah* will never forget the moment her life split in two: the time when she was blissfully unaware, and the "after", when ...
Before the onset of the SUV-pandemic, when it came to family haulers there was only one choice - the station wagon. Wheels ...
Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of ...
MMS has long been promoted as a miracle cure, but new research shows it’s essentially a toxic disinfectant. While it can kill ...
Herpes simplex virus (HSV) encephalitis, caused by HSV types 1 and 2, is the most common sporadic viral encephalitis worldwide, with an annual incidence of around 2·2–4·6 per million people.1 Before ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The funds will extend the ...
Oral sex is often considered safer than penetrative sex but it is not completely risk-free What are the risks of oral sex Our expert explains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results